Printer Friendly

MEDISYS TECHNOLOGIES AND BAYLOR COLLEGE OF MEDICINE ANNOUNCE FORMAL SIGNING OF CLINICAL TRIALS AGREEMENT

 BATON ROUGE, La., Oct. 15 /PRNewswire/ -- Medisys Technologies, Inc. (OTC Bulletin Board: SCEP), a Baton Rouge-based company, and Baylor College of Medicine, Houston, today announced formal signing of a clinical trials agreement.
 Under the direction of Kenneth J. Moise Jr., M.D., Division of Maternal/Fetal Medicine, Department of Obstetrics and Gynecology, Baylor, will begin the initial phase of human clinical testing of the new Medisys birth assistance device, SofCeps(R). The device has been under development for the past two years by Medisys as a less traumatic alternative to traditional obstetrical steel forceps and vacuum extractors. SofCeps(R) is a disposable soft and thin double-walled multifiber braided axial gripping cylinder which is placed over the fetal skull with a simple application system. The device is designed to uniformly distribute assisting traction forces about the circumference of the fetal skull. Gary Alexander, executive vice president of Medisys, stated that Medisys believes the tests will demonstrate that the device has potential for reduction of birth injuries and potential for reduction of Cesarean section delivery rates. Tests will be conducted at Ben Taub General Hospital in Houston.
 -0- 10/15/93
 /CONTACT: Edward P. Sutherland, president and CEO of Medisys, 504-926-0422/
 (SCEP)


CO: Medisys Technologies, Inc.; Baylor College of Medicine ST: Louisiana, Texas IN: MTC SU:

RA-BN -- AT004 -- 2685 10/15/93 11:09 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 15, 1993
Words:223
Previous Article:FRANKLIN ELECTRIC DECLARES PAYMENT OF QUARTERLY CASH DIVIDEND ON COMMON STOCK
Next Article:EARNINGS AND GROWTH ON THE RISE FOR F&M BANCORPORATION
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters